TORONTO, ONTARIO — (Marketwired) — 06/19/15 — Off the heels of its presence at Klick Ideas Exchange earlier this week, ARHT Media Inc. (TSX VENTURE: ART)(OTCQB: ARHTF) today announced the second successful go-to-market application of its exclusive holographic technology with Klick Health at the 2015 BIO International Convention.
ARHT presented Leerom Segal, co-founder and CEO of Klick Health, as a HumaGram, a top-of-the-range, fully interactive and intelligent human hologram, introducing the convention–s keynote speaker Dr. Eric Topol, M.D., Director of Scripps Translational Science Institute; former Chair of Cleveland Clinic–s Department of Cardiovascular Medicine; and author of The Patient Will See You Now.
ARHT, makers of these advanced human holograms, specializes in enabling HumaGram presentations, like the one facilitated for the first implementation at Klick Ideas Exchange by Larry King and now at the BIO International Convention through Leerom Segal–s speech. With HumaGrams, the biotech C-suite can now think at a much larger scale about the speakers market in the industry. Through HumaGrams, as well as the rest of its 3D displays, ARHT can collect data and offer a full suite of proximity analytics, which can provide insights such as the number of people who saw the content, those that continued to engage and much more. This will allow for very targeted messaging and much higher rates of awareness and, potentially, conversion.
In reference to its second commercial application with Klick, Paul Duffy, CEO of ARHT said, “Being at an event at the heart of the U.S. Biopharma industry, with the ability to present the kind of technology that will be the future of digital health, is an honor. Leerom Segal presenting as a HumaGram is a great example of how leaders in healthcare, bio and big Pharma can unlock the potential to be in multiple locations across the globe, at the same time, through our “Holo-porting” technology, with full interactivity, just like you would have with a human being.”
The BIO International Convention hosts thousands of visitors in the biotech space each year, including Chief Commercial Officers who are on the lookout for ways to take their innovations to market and present to their key audiences in newly engaging and effective ways. Through ARHT–s suite of 3D, holographic and proximity marketing technology, the biotech and pharma industry can showcase high-impact content at healthcare speaking engagements, medical conferences and other events.
Following the strategic partnership with Klick signed a few weeks ago, this is ARHT–s second major event taking their joint solution to market.
About ARHT Media
ARHT Media Inc. creates HumaGrams, the most believable and interactive human holograms. HumaGrams are generated using our patent-pending Augmented Reality Holographic Technology (ARHT), which is a scalable, repeatable and transportable form of 3D without the use of special glasses. This unique platform makes it possible for people to engage with our HumaGrams, opening up a wide range of applications from interactive retail displays, tradeshow booths, presentations, live shows and concerts. The various applications can then be integrated into multiple forms of proximity and mobile marketing tactics to connect with an audience, drive sales efforts and create memorable experiences.
ARHT Media Inc. was co-founded in 2012, by Rene Bharti (Chairman), and entertainer Paul Anka (Chairman, Board of Advisors). The company is supported by a diverse and seasoned Management team spearheaded by its CEO Paul Duffy, a global entrepreneur and creator of the Digital Human Experience in online, mobile and holographic communications. ARHT–s team brings decades of experience from fields including entertainment, technology, marketing and finance. Advisors to the company include the likes of Larry King, Jason Bateman, Richard “Skip” Bronson, Michael Buble, Carlos Slim, Irving Azoff and Kevin O–Leary.
ARHT Media trades under the symbol ART on the Toronto Venture Stock Exchange and the OTCQB Exchange under the symbol ARHTF.
Connect With ARHT On Social Media:
Twitter:
Facebook:
LinkedIn:
For more information, please visit or contact the investor relations group at .
This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. Forward-looking information includes, but is not limited to, statements with respect to ARHT–s Strategic partnership with Klick Inc.; the company–s technology; the potential uses for the company–s technology; the ability of the company to monetize the HumaGram technology; and how the company–s technology will impact education and speaking marketplace and particular industries such as the biotech or pharmaceutical industries. Generally, forward looking information can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved”. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking information, including but not limited to: general business, economic and competitive uncertainties; regulatory risks; risks inherent in technology operations; and other risks of the technology industry. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws.
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
Contacts:
Marilia Bento
Managing Director – Strategic Development
1-800-490-9210
You must be logged in to post a comment Login